| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
With more than 30 years of experience marketing to healthcare professionals, patients, and consumers, FCB Health produces work that is both strategically relevant and creatively compelling. We provide clients with multichannel capabilities, including payer strategy and marketing, professional education, video production, strategic planning, and media services.
uLab | PDA is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Adar Medical Uniforms brand has been well known in the medical uniforms industry since 1971. That`s over 40 years of experience providing top of line uniforms and excellent customer service. Our products are known for their fine quality, comfort, and fashionable styling. The Adar development team spends hours on end creating beautiful thought out designs that are also practical to the discerning professional. Each style is inspected and reviewed assuring that the uniforms are of the highest quality.
Anthem, Inc., is a provider of health insurance in the United States.